[1] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA A Cancer J Clin, 2022, 72(1):7-33.
|
[2] |
Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment[J]. Technol Cancer Res Treat, 2020, 19: 1533033820962117.
|
[3] |
Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis[J]. Cancer Lett, 2021, 520:1-11.
|
[4] |
Tempero MA. NCCN guidelines updates: pancreatic cancer[J]. J Natl Compr Canc Netw, 2019, 17(5.5):603-605.
|
[5] |
Masiak-Segit W, Rawicz-Pruszyński K, Skórzewska M, et al. Surgical treatment of pancreatic cancer[J]. Pol Przegl Chir, 2018, 90(2):45-53.
|
[6] |
Min SK, You Y, Choi DW, et al. Prognosis of pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(9):1004-1013.
|
[7] |
Karunakaran M, Barreto SG. Surgery for pancreatic cancer: current controversies and challenges[J]. Future Oncol, 2021, 17(36):5135-5162.
|
[8] |
Varshney VK. Pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(11):e116.
|
[9] |
Arrington AK, Price ET, Golisch K, et al. Pancreatic cancer lymph node resection revisited: a novel calculation of number of lymph nodes required[J]. J Am Coll Surg, 2019, 228(4):662-669.
|
[10] |
Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)[J]. Surgery, 2014, 156(3):591-600.
|
[11] |
Ignjatovic I, Knezevic S, Knezevic D, et al. Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma[J]. J BUON, 2017, 22(1):232-238.
|
[12] |
Pu N, Mu S, Fang Y, et al. Survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study[J]. Transl Cancer Res, 2020, 9(3):1476-1486.
|
[13] |
Lin Q, Zheng S, Yu X, et al. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial[J]. Cancer Commun, 2023, 43(2):257-275.
|
[14] |
Guo X, Song Y, Xu P, et al. Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study[J]. Int J Surg, 2023, 109(7):1852-1862.
|
[15] |
Wang Z, Ke N, Wang X, et al. Optimal extent of lymphadenectomy for radical surgery of pancreatic head adenocarcinoma: 2-year survival rate results of single-center, prospective, randomized controlled study[J]. Medicine, 2021, 100(35):e26918.
|
[16] |
Imamura T, Yamamoto Y, Sugiura T, et al. Reconsidering the optimal regional lymph node station according to tumor location for pancreatic cancer[J]. Ann Surg Oncol, 2021, 28(3):1602-1611.
|
[17] |
Qian L, Xie J, Xu Z, et al. The necessity of dissection of No. 14 lymph nodes to patients with pancreatic ductal adenocarcinoma based on the embryonic development of the head of the pancreas[J]. Front Oncol, 2020, 10: 1343.
|
[18] |
Mirkin KA, Hollenbeak CS, Wong J. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer[J]. J Surg Res, 2017, 220: 12-24.
|
[19] |
Rahim MK, Okholm TLH, Jones KB, et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell, 2023, 186(6):1127-1143, e18.
|
[20] |
杨尹默, 李宝毅, 马永蔌. 胰腺癌免疫治疗现状与进展[J]. 中华普通外科杂志, 2023, 38(5):321-325
|
[21] |
Huang Q, Wu X, Wang Z, et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes[J]. Cell, 2022, 185(22):4049-4066, e25.
|